Why the study?
Does enalapril initiated intravenously within 24 h after acute myocardial infarction improve cardiac output and peripheral resistance in patients after acute myocardial infarction?
Does enalapril initiated intravenously within 24 h after acute myocardial infarction improve cardiac output and peripheral resistance in patients after acute myocardial infarction?
Early intravenous enalapril after acute myocardial infarction does not generally improve cardiac output, but may provide a small benefit in patients with an ejection fraction ≥45% by reducing peripheral resistance.
Answers are grounded in this paper and cite their sources.
Early IV ACE inhibition does not improve cardiac output post-MI; challenges routine early use and leaves preserved-EF subgroup benefit open.
In the Cooperative New Scandinavian Enalapril Survival Study (CONSENSUS II), in which enalapril treatment was initiated intravenously within 24 h after acute myocardial infarction, there was a neutral effect on 6-month mortality, whereas a beneficial effect on the progression of congestive heart failure was noted. We studied the effect of enalapril on left ventricular systolic function in terms of cardiac output and mean acceleration time measured by pulsed-wave Doppler in the left ventricular outflow tract and peripheral resistance. Early angiotensin-converting enzyme inhibition after acute myocardial infarction did not result in a general improvement of cardiac output. However, a small increase in cardiac output was observed in a subgroup of enalapril-treated patients with ejection fraction > or = 45%, probably due to a reduction in peripheral resistance in these patients.
No takes yet. Share an insight, caveat, or question.
Edner et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: